Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study
Sherif S. Farag(Ain Shams University), Clara D. Bloomfield(North Shore University Hospital), Robert J. Mayer(Applied Natural Sciences), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Richard M. Stone(Dana-Farber Cancer Institute), Prasad Koduru(University of Maryland, Baltimore), Richard A. Larson(Urbana University), Andrew J. Carroll(University of Alabama at Birmingham), Joseph O. Moore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Krzysztof Mrózek(The Ohio State University), Bayard L. Powell(Atrium Health Wake Forest Baptist), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), James W. Vardiman(University of Chicago), Mark J. Pettenati, Judith Stamberg(University of Maryland, Baltimore), Charles A. Schiffer(Veterans Health Administration), AnneMarie W. Block(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Maria R. Baer(University of Maryland, Baltimore)
Cited by 138
Related Papers
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
|Blood|2016|10.2k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k